Viewing Study NCT04000490



Ignite Creation Date: 2024-05-06 @ 1:22 PM
Last Modification Date: 2024-10-26 @ 1:12 PM
Study NCT ID: NCT04000490
Status: COMPLETED
Last Update Posted: 2020-09-01
First Post: 2019-06-07

Brief Title: External Validation of the SCARE Score
Sponsor: Centre Hospitalier Régional dOrléans
Organization: Centre Hospitalier Régional dOrléans

Study Overview

Official Title: Validation of the SCARE Score Predictive Score of Acute Coronary Syndrome During the Assessment of Chest Pain in the Call Center
Status: COMPLETED
Status Verified Date: 2020-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SCARE
Brief Summary: Chest pain is a very common reason for resorting to the call center The etiologies are very varied ranging from benign pathologies to some that may involve in the short term the vital prognosis such as Acute Coronary Syndrome ACS ACS is a partial or complete occlusion of a coronary artery that causes potentially irreversible myocardial pain unless prompt treatment is undertaken ACS represents 120 000 cases per year in France and causes about 18 000 deaths There is currently no support score for the assessment of chest pain However reducing the duration of management of ACS is essential in order to hope to reduce the associated morbidity and mortality In 2016 SAMU45s team established a predictive ACS score for the assessement of chest pain in SAMU 45 France based on the prospective study of 1367 patients Seven items significantly associated with this risk of ACS could be highlighted age sex smoking typicality potentially constrictive chest pain radiating potentially to the shoulders and or jaw pain inaugural character of pain ie first episode of this type presence of sweats and the physicians belief to be in the presence of an ACS These seven variables make up the SCARE score This had good internal discrimination AUC at 081 and excellent calibration p of Hosmer-Lemeshow at 074 This score makes it possible to stratify the risk of ACS by using epidemiological elements but also the physicians belief whose Negative Predictive Value VPN proved excellent

The objective of this new project is to confirm by an external validation via a multicentric study the robustness of this score and thus be able to consider its use in front of any chest pain regulated in France by a call center
Detailed Description: The main objective is to validate the predictive SCARE score of acute coronary syndrome during the medical assessment of chest pain The primary endpoint will be SCARE score analysis pre-established in 2016 with assessment of its calibration Hosmer Lemeshow and discrimination AUC in a multicenter population of chest pain with a potential diagnosis of Acute Coronary Syndrome established according to the European Society of Cardiology criteria

This is a multi-center study including any patient over 18 years of age calling call center for chest pain over a period of six months It will exclude post-traumatic chest pain patients under 18 years old patients who do not speak French patients refusing to participate in the study or refusing treatment patients not affiliated to social security patients incarcerated in a penitentiary center patients under tutorship curatorship or safeguard of justice

The collection of data will be carried out thanks to files filled prospectively by the medical physician for each call for the reason of a chest pain These cards will list the epidemiological data age sex weight height and clinical data of each patient as well as the decision and the resources committed by the regulating physician hospital care via SMUR or ambulance treatment in city medicine For hospitalized patients the diagnosis of ACS will be retained if the patient meets the criteria defined by the European Society of Cardiology For patients managed in ambulatory medicine a telephone call to the patient will be made at one month to obtain the diagnosis

Then the SCARE score will be analized in this multicenter population with evaluation of its calibration Hosmer Lemeshow and discrimination AUC The characteristic performances of the score sensitivity specificity PPV NPV positive and negative likelihood ratioswill also be analized

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None